Attention Deficit Hyperactivity Disorder: Drugs

Department of Health and Social Care written question – answered at on 21 November 2023.

Alert me about debates like this

Photo of Greg Clark Greg Clark Chair, Science, Innovation and Technology Committee, Chair, Science, Innovation and Technology Committee

To ask the Secretary of State for Health and Social Care, what steps the Government is taking to tackle shortages in the ADHD medication supply.

Photo of Greg Clark Greg Clark Chair, Science, Innovation and Technology Committee, Chair, Science, Innovation and Technology Committee

To ask the Secretary of State for Health and Social Care, what steps the Government is taking to help strengthen global supply chains of ADHD medications to help prevent shortages in the supply of those medications.

Photo of Andrew Stephenson Andrew Stephenson Assistant Whip, Minister of State (Department of Health and Social Care)

We are aware of disruptions to the supply of medicines used for the management of Attention Deficit and Hyperactivity Disorder (ADHD), primarily driven by issues which have resulted in capacity constraints at key manufacturing sites.

We understand how frustrating and distressing medicine shortages can be and we want to assure patients that we are working with the respective manufacturers to resolve the issues as soon as possible and to ensure patients have continuous access to ADHD medicines in the United Kingdom, in the short and long term.

We have issued communications to the National Health Service to advise healthcare professionals on management of patients whilst there continue to be disruptions to supplies. Patients are advised to speak to their clinician regarding any concerns they have and to discuss the suitability of treatment with alternative medicines.

Does this answer the above question?

Yes0 people think so

No1 person thinks not

Would you like to ask a question like this yourself? Use our Freedom of Information site.